Lamotrigine Tablet, Extended Release — FDA Drug Shortage
The FDA lists a drug shortage record for Lamotrigine Tablet, Extended Release (tablet) from Par Health, Inc. with status To Be Discontinued. The shortage was first posted on 04/29/2026.
Shortage Details
- Status
- To Be Discontinued
- Company
- Par Health, Inc.
- Package NDC
- 49884-604-11
- Dosage Form
- Tablet
- Presentation
- Lamotrigine, Tablet, Extended Release, 250 mg (NDC 49884-604-11)
- Initial Posting
- 04/29/2026
- Revised Date